A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the ...
F2G submitted its initial approval application with data from the first 100 patients enrolled in a phase 2b study of the drug ...
An innovative study for the treatment of post-COVID syndrome (PCS) is starting under the direction of Frankfurt University Hospital’s Department of Infectious Diseases. The research project, funded by ...
An innovative study for the treatment of post-COVID syndrome (PCS) is starting under the direction of Frankfurt University Hospital’s Department of Infectious Diseases. The research project, funded by ...
Metabolic rewiring is essential for osteoclast differentiation and bone resorption. This study shows that glutaminolysis ...